Do lycium barbarum polysaccharides protect rat liver from non-alcoholic steatohepatitis-induced injury?
LBP is a novel hepatoprotective agent against NASH caused by abnormal liver metabolic functions.
In conclusion, in vivo sensitivity of gastric cancer xenografts to BEZ235 did not correlate with in vitro antiproliferative activity or in vivo PI3K/mTOR target inhibition by BEZ235. In contrast, [(18)F]FLT uptake was linked to BEZ235 in vivo sensitivity. Noninvasive [(18)F]FLT PET imaging might qualify as a novel marker for optimizing future clinical testing of dual PI3K/mTOR inhibitors.